64x Bio Raises $55M To Advance Gene Therapy Platform
By Janice Bitters Turi, San Francisco-based gene therapy biotech company 64x Bio has raised $55 million to advance its gene therapy manufacturing platform, which company officials and investors say could “revolutionize the economics and accessibility of gene therapy.” The raise comes as many investors say gene therapy is poised to make waves in the biotech industry. The[…]